Sudbury, MA, United States of America

Robert Sanzone

USPTO Granted Patents = 3 

Average Co-Inventor Count = 9.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Robert Sanzone

Introduction

Robert Sanzone is a notable inventor based in Sudbury, MA (US), recognized for his contributions to the field of medical technology. With a total of 3 patents to his name, Sanzone has made significant strides in developing devices that enhance patient care and medication delivery.

Latest Patents

One of Sanzone's latest inventions is an automated drug delivery device. This wearable micro-dosing drug delivery device is designed to provide basal-only dosing of insulin. The device operates automatically and features audible alerts and visual status indicators to keep patients informed. Additionally, it allows patients to have some control over its operation through tapping gestures on the device's housing. Furthermore, patients can interact with the device via a mobile application that communicates wirelessly with the wearable drug delivery device.

Career Highlights

Sanzone's career is marked by his work at Insulet Corporation, where he has been instrumental in advancing innovative medical technologies. His expertise in developing user-friendly devices has contributed to improving the quality of life for patients requiring insulin therapy.

Collaborations

Some of Sanzone's coworkers include Matthew Alles and Derek Rund, who have collaborated with him on various projects within the company.

Conclusion

Robert Sanzone's innovative work in the field of medical technology, particularly in automated drug delivery systems, showcases his commitment to enhancing patient care. His contributions continue to make a significant impact in the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…